Skip to content
10-Q

Quarterly Report

HYPERION THERAPEUTICS INC

0001193125-14-303161

← back to feed
Filed
Aug 8, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 5, 2014 20.6M sh
Shares Diluted Q2 2014 · Jun 30, 2014 21.61M sh
Shares Diluted Q2 2014 · Jun 30, 2014 21.57M sh
Capex Q2 2014 · Jun 30, 2014 $291K
Short Term Investments Q2 2014 · Jun 30, 2014 $42.28M
Short Term Investments Q2 2014 · Dec 31, 2013 $28.05M
Cash And Equivalents Q2 2014 · Jun 30, 2014 $80.64M
Cash And Equivalents Q2 2014 · Dec 31, 2013 $74.23M
Stockholders Equity Q2 2014 · Jun 30, 2014 $150.77M
Stockholders Equity Q2 2014 · Dec 31, 2013 $119.69M
Current Liabilities Q2 2014 · Jun 30, 2014 $43.24M
Current Liabilities Q2 2014 · Dec 31, 2013 $20.13M
Total Liabilities Q2 2014 · Jun 30, 2014 $151.41M
Total Liabilities Q2 2014 · Dec 31, 2013 $22.83M
Current Assets Q2 2014 · Jun 30, 2014 $146.23M
Current Assets Q2 2014 · Dec 31, 2013 $111.61M
Total Assets Q2 2014 · Jun 30, 2014 $302.18M
Total Assets Q2 2014 · Dec 31, 2013 $142.52M
Eps Diluted Q2 2014 · Jun 30, 2014 $0.81
Eps Diluted Q2 2014 · Jun 30, 2014 $0.87
Eps Basic Q2 2014 · Jun 30, 2014 $0.86
Eps Basic Q2 2014 · Jun 30, 2014 $0.92
Sga Expense Q2 2014 · Jun 30, 2014 $11.37M
Sga Expense Q2 2014 · Jun 30, 2014 $22.54M
Rd Expense Q2 2014 · Jun 30, 2014 $4.05M
Rd Expense Q2 2014 · Jun 30, 2014 $7.26M
Net Income Q2 2014 · Jun 30, 2014 $17.48M
Net Income Q2 2014 · Jun 30, 2014 $18.74M
Operating Income Q2 2014 · Jun 30, 2014 $15.49M
Operating Income Q2 2014 · Jun 30, 2014 $17.19M
Cost Of Revenue Q2 2014 · Jun 30, 2014 $4.47M
Cost Of Revenue Q2 2014 · Jun 30, 2014 $6.86M
Revenue Q2 2014 · Jun 30, 2014 $37.1M
Revenue Q2 2014 · Jun 30, 2014 $56.58M